Kontakt

Dr. sc. Piero Marin Živković

Gastroenterolog
Gastroenterologija:
- Ultrazvuk abdomena
- Kolonoskopija
- Gastroskopija
Zivkovic PM, Matetic A, Tadin Hadjina I, Rusic D, Vilovic M, Supe-Domic D et al. Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease. J Clin Med. 2020 Feb 26;9(3):628.
Vrdoljak J, Vilović M, Živković PM, Tadin Hadjina I, Rušić D, Bukić J et al. Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease. Nutrients. 2020 Nov 8;12(11):3429.
Tadin Hadjina I, Zivkovic PM, Matetic A, Rusic D, Vilovic M, Bajo D et al. Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease. Sci Rep. 2019 Sep 24;9(1):13740.
Rusic D, Bozic J, Vilovic M, Bukic J, Zivkovic PM, Leskur D et al. Attitudes and Knowledge Regarding Antimicrobial Use and Resistance Among Pharmacy and Medical Students at the University of Split, Croatia. Microb Drug Resist. 2018 Dec;24(10):1521-1528.
Miličević T, Kolčić I, Đogaš T, Živković PM, Radman M, Radić J. Nutritional Status and Indicators of 2-Year Mortality and Re-Hospitalizations: Experience from the Internal Clinic Departments in Tertiary Hospital in Croatia. Nutrients. 2020 Dec 28;13(1):68.
Kumric M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, Vilovic M et al. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics (Basel). 2021 Dec 27;12(1):45.
Kumric M, Ticinovic Kurir T, Martinovic D, Zivkovic PM, Bozic J. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence. World J Gastroenterol. 2021 Jul 7;27(25):3748-61.
Jukic I, Rusic D, Vukovic J, Zivkovic PM, Bukic J, Leskur D et al. Correlation of registered drug packs with Maastricht V/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection. Basic Clin Pharmacol Toxicol. 2020 Mar;126(3):212-25.
Franić I, Režić-Mužinić N, Markotić A, Živković PM, Vilović M, Rušić D, Božić J. Expression of CD44 in Leukocyte Subpopulations in Patients with Inflammatory Bowel Diseases. Diagnostics (Basel). 2022 Aug 20;12(8):2014.
Brnic D, Martinovic D, Zivkovic PM, Tokic D, Vilovic M, Rusic D et al. Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease. World J Gastroenterol. 2020 Aug 28;26(32):4866-77.
Brnić D, Martinovic D, Zivkovic PM, Tokic D, Tadin Hadjina I, Rusic D et al. Serum adropin levels are reduced in patients with inflammatory bowel diseases. Sci Rep. 2020 Jun 9;10(1):9264.
Bezić J, Šamija Projić I, Projić P, Meljanac Salopek K, Živković PM, Božić J, Tomić S. Pathobiology of HER 2 positive small invasive (T1a,b) breast cancer: "A wolf in sheep's clothing". Pathol Res Pract. 2017 Dec;213(12):1510-1514.
Bezić J, Karaman I, Zekić Tomaš S, Živković PM, Božić J. Osteonevus of Nanta Revisited: Clinicopathological Features of 33 Cases. Am J Dermatopathol. 2016 Nov;38(11):859-61.
Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M et al. Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol. 221 Sep 28;27(36):6142-53.

Kontakt

ZA SVE INFORMACIJE O PREGLEDIMA I NARUDŽBAMA,
OBRATITE NAM SE S POVJERENJEM

Otvori chat
Slobodno pitajte
Poštovani, kako Vam možemo pomoći?